Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Incannex Healthcare Inc. (IXHL)

Incannex Receives Final A$5.1 Million R&D Tax Incentive Refund

Neutral Impact 2 of 5 other Written later

Incannex Healthcare said it received a final A$5,102,788.30 refund under the Australian Government's Research and Development Tax Incentive Program, after the amended FY25 income tax return was approved. The company says this brings its 2026 non-dilutive receipts under this program to more than A$11.2 million, with no shareholder dilution. The filing reports no change to revenue, earnings, or guidance.

Key points

  • Final refund of A$5,102,788.30 received, announced August 11, 2026
  • Previously announced refund of A$6,039,162.43 brings 2026 total to more than A$11.2 million
  • Refund follows Australian government approval of overseas findings and amendment of the FY25 income tax return
  • Company expects additional R&D Tax Incentive funding in 2027 for eligible ongoing activities

The filing

CompanyIncannex Healthcare Inc. (IXHL)
Form8-K, current report
Filed with the SECAug 11, 2026, 7:30 AM ET
Accession number0001213900-26-087493

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.